论文信息 - Personalized medicine: Time for one-person trials

Personalized medicine: Time for one-person trials

Precision medicine requires a different type of clinical trial that focuses on individual, not average, responses to therapy, says Nicholas J. Schork.

N. Schork

[1] C. Sawyers,et al. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. , 2001, The New England journal of medicine.

[2] E. Topol,et al. Pharmacogenomics in cardiovascular diseases. , 2002, Progress in cardiovascular diseases.

[3] B. Lipworth,et al. Long-Acting β2-Agonists in Asthma , 2006 .

[4] Dongsheng Tu,et al. K-ras mutations and benefit from cetuximab in advanced colorectal cancer. , 2008, The New England journal of medicine.

[5] Paul Glasziou,et al. Using N-of-1 Trials to Improve Patient Management and Save Costs , 2010, Journal of General Internal Medicine.

[6] V. Fedorov,et al. Responder Analyses—A PhRMA Position Paper , 2011 .

[7] Hugo Y. K. Lam,et al. Personal Omics Profiling Reveals Dynamic Molecular and Medical Phenotypes , 2012, Cell.

[8] C. Berg,et al. Longitudinal screening algorithm that incorporates change over time in CA125 levels identifies ovarian cancer earlier than a single-threshold rule. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.